Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
The Annals of Pharmacotherapy
|
March 16, 2002
Surrogate end points in heart failure
Craig R Lee, Kirkwood F Adams, J Herbert Patterson
Heart Failure Clinics
|
September 14, 2014
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients
Tess E Lin, Kirkwood F Adams, J Herbert Patterson
Pharmacotherapy
|
April 11, 2017
Integrating New Pharmacologic Agents into Heart Failure Care: Role of Heart Failure Practice Guidelines in Meeting This Challenge
Kirkwood F Adams, Erika M Giblin, Natalie Pearce, et al.
Journal of Cardiac Failure
|
April 3, 2012
Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new
Jasmine A Talameh, Howard L McLeod, Kirkwood F Adams, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 23, 2016
Evolving therapies for the management of chronic and acute decompensated heart failure
Jennifer C Cook, Richard H Tran, J Herbert Patterson, et al.
Expert Review of Cardiovascular Therapy
|
June 2, 2015
Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials
Jeff Fajardo, J Thomas Heywood, J Herbert Patterson, et al.
The American Journal of Cardiology
|
October 3, 2008
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management
Eric D Peterson, Nancy M Albert, Alpesh Amin, et al.
Heart Failure Reviews
|
April 21, 2009
Biomarker guided therapy for heart failure: focus on natriuretic peptides
Kirkwood F Adams, G Michael Felker, Ghassan Fraij, et al.
Journal of Clinical Medicine
|
August 4, 2015
Review of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions
Purav R Bhatt, Elizabeth B McNeely, Tess E Lin, et al.
Journal of the American College of Cardiology
|
March 19, 2002
Clinical benefits of low serum digoxin concentrations in heart failure
Kirkwood F Adams, Mihai Gheorghiade, Barry F Uretsky, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
The Annals of Pharmacotherapy
|
March 16, 2002
Surrogate end points in heart failure
Craig R Lee, Kirkwood F Adams, J Herbert Patterson
Heart Failure Clinics
|
September 14, 2014
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients
Tess E Lin, Kirkwood F Adams, J Herbert Patterson
Pharmacotherapy
|
April 11, 2017
Integrating New Pharmacologic Agents into Heart Failure Care: Role of Heart Failure Practice Guidelines in Meeting This Challenge
Kirkwood F Adams, Erika M Giblin, Natalie Pearce, et al.
Journal of Cardiac Failure
|
April 3, 2012
Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new
Jasmine A Talameh, Howard L McLeod, Kirkwood F Adams, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 23, 2016
Evolving therapies for the management of chronic and acute decompensated heart failure
Jennifer C Cook, Richard H Tran, J Herbert Patterson, et al.
Expert Review of Cardiovascular Therapy
|
June 2, 2015
Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials
Jeff Fajardo, J Thomas Heywood, J Herbert Patterson, et al.
The American Journal of Cardiology
|
October 3, 2008
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management
Eric D Peterson, Nancy M Albert, Alpesh Amin, et al.
Heart Failure Reviews
|
April 21, 2009
Biomarker guided therapy for heart failure: focus on natriuretic peptides
Kirkwood F Adams, G Michael Felker, Ghassan Fraij, et al.
Journal of Clinical Medicine
|
August 4, 2015
Review of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions
Purav R Bhatt, Elizabeth B McNeely, Tess E Lin, et al.
Journal of the American College of Cardiology
|
March 19, 2002
Clinical benefits of low serum digoxin concentrations in heart failure
Kirkwood F Adams, Mihai Gheorghiade, Barry F Uretsky, et al.
Page
of 7